Company Information

  

Address: 6275 NANCY RIDGE DRIVE
SUITE 110 
City: SAN DIEGO 
State: CA 
Zip Code: 92121 
Telephone: 858-224-1000 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Organovo Holdings, Inc. ("Organovo Holdings," "we," "us," "our," "the Company" and "our Company") is a biotechnology company pioneering the development of bioprinted human tissues that emulate human biology and disease. Initially, we are developing our in vivo liver tissues to treat end-stage liver disease and a select group of life-threatening, orphan diseases, for which there are limited treatment options other than organ transplantation. Our objective is to serve as a `bridge-to-transplant' for these patients, with an ultimate goal of delaying or reducing the overall need for transplant. The Company's program focused on an orphan disease known as Alpha-1-antitrypsin deficiency ("A1AT"), received the U.S. Food and Drug Administration's ("FDA") orphan drug designation in December 2017.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2019-0.21NAN/E
03/2019-0.23NAN/E
12/2018-0.23NAN/E
09/2018-0.25NAN/E
06/2018-0.29NAN/E
03/2018-0.32NAN/E
12/2017-0.36NAN/E
09/2017-0.38NAN/E

Key Financial Ratios and Statistics

FYE: 03/31

Profitability 2019 Leverage 2019
Net Inc/Comm Equity-0.09Total Liab/Total Assets0.11
Net Inc/Total Assets-0.66Total Liab/Inv Cap0.12
Net Inc/Inv Cap-0.72Total Liab/Comm Equity0.01
Pretax Inc/Net Sales-8.62Interest Coverage RatioNA
Net Inc/Net Sales-8.62Curr Debt/EquityNA
Cash Flow/Net Sales-6.59LTD/EquityNA
SG&A/NetSales4.90Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover3.90Quick Ratio10.19
Inventory Turnover0.72Current Ratio10.32
Inventory Day Sales0.00Net Rec/Curr Assets0.01
Net Sales/Work Cap0.09Inv/Curr Assets0.01
Net Sales/PP&E1.69  

Income Statement (Millions)

  6/30/2019 3/31/2019 12/31/2018 9/30/2018
Total Revenues(Net Sales) 0.67 0.68 0.78 0.94
Cost of Goods Sold 0.05 0.10 0.14 0.13
Selling & Admin Exps 3.32 3.34 3.39 3.64
Operating Income -6.52 -7.16 -6.53 -6.01
Interest Exp NA NA NA NA
Pretax Income -6.32 -6.98 -6.40 -5.84
Other Income 0.20 0.18 0.13 0.17
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -6.32 -6.98 -6.40 -5.84

Balance Sheet (Millions)

Assets 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Cash & Short Term Investments 35.49 36.48 35.22 37.36
Receivables - Total 0.64 0.56 0.67 0.93
Inventories - Total 0.51 0.49 1.05 1.04
Total Current Assets 37.36 38.57 37.47 40.12
Net Property, Plant & Equipment 5.88 1.83 1.95 2.24
Total Assets 43.45 40.62 39.69 42.63
Liabilities        
Accounts Payable 1.96 3.18 2.80 2.48
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 3.54 3.74 3.41 3.29
Long-Term Debt NA NA NA NA
Total Liabilities 7.31 4.33 4.01 3.76
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.13 0.12 0.12 0.12
Retained Earnings -267.08 -260.76 -253.77 -247.37
Treasury Stock NA NA NA NA
Total Stockholders' Equity 36.14 36.30 35.68 38.87
Total Liabilities and Stockholders' Equity 43.45 40.62 39.69 42.63

Cash Flow Summary (Millions)

Categories 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Net Cash Provided by Operating Activities -5.94 -5.08 -3.95 -4.32
Net Cash Provided by Investing Activities 0.00 -0.04 -0.03 -0.01
Net Cash Provided by Financing Activities 4.94 6.32 1.85 2.08

Annual Summary Data (Millions)

Year Sales Net Income EPS
03/20150.57-30.08-0.38
03/20161.48-38.58-0.43
03/20174.23-38.45-0.39
03/20184.60-34.80-0.32
03/20193.09-26.64-0.23
Growth Rates52.53----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1912357,50344.14




Report Date : 9/9/2019

Powered By Edgar Online © 2019EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.